N

NeoPharm Co Ltd
KOSDAQ:092730

Watchlist Manager
NeoPharm Co Ltd
KOSDAQ:092730
Watchlist
Price: 19 100 KRW -0.98% Market Closed
Market Cap: 306.2B KRW

Wall Street
Price Targets

Price Targets Summary
NeoPharm Co Ltd

There are no price targets for NeoPharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NeoPharm Co Ltd Competitors:
Price Targets
600315
Shanghai Jahwa United Co Ltd
7% Upside
USNA
USANA Health Sciences Inc
99% Upside
NTCO3
Natura & Co Holding SA
23% Upside
051900
LG H&H Co Ltd
12% Upside
300957
Yunnan Botanee Bio-Technology Group Co Ltd
12% Upside
BRBR
Bellring Brands Inc
41% Upside
1044
Hengan International Group Company Ltd
9% Downside
PHN
Pharmanutra SpA
54% Upside

Revenue
Forecast

Revenue Estimate
NeoPharm Co Ltd

For the last 13 years the compound annual growth rate for NeoPharm Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 10%.

16%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
NeoPharm Co Ltd

For the last 13 years the compound annual growth rate for NeoPharm Co Ltd's operating income is 26%. The projected CAGR for the next 3 years is 13%.

26%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
NeoPharm Co Ltd

For the last 13 years the compound annual growth rate for NeoPharm Co Ltd's net income is 28%. The projected CAGR for the next 3 years is 11%.

28%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NeoPharm Co Ltd's stock price target?
Not Available

NeoPharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is NeoPharm Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 13 years the compound annual growth rate for NeoPharm Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 10%.

What is NeoPharm Co Ltd's Operating Income forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for NeoPharm Co Ltd's operating income is 26%. The projected CAGR for the next 3 years is 13%.

What is NeoPharm Co Ltd's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for NeoPharm Co Ltd's net income is 28%. The projected CAGR for the next 3 years is 11%.

Back to Top